Innovations In Medical Treatment Research Articles

Medicinski tretman i prevencija Helikobakter pilori infekcije

Helicobacter pylori infection is one of the most commonly treated infections in gastroenterology. In the last three decades, due to recurrent or repeated infection, the incidence of this complex health problem has been constantly increasing. Studies have shown that successful treatment of this infection can prevent the occurrence of numerous complications, such as ulcer disease, dyspepsia or gastric cancer. Interventions in the prevention of Helicobacter pylori infection are numerous, they are carried out at all levels of health care and are of great importance for reducing the number of patients, but also for the occurrence of complications related to the infection. The aim of this paper is to evaluate innovations in medical treatment and prevention of Helicobacter pylori infection.

Gross Domestic Product and Health Expenditure Growth in Balkan and East European Countries-Three-Decade Horizon.

Background: Dynamics of health care has changed over time along with development of the countries themselves. The aim of the study is to compare macroeconomic and health expenditure indicators of interest, such as total health expenditure (THE) as percentage of global domestic product, global domestic product per capita in US$, and private households' out-of-pocket payments of Balkan and Eastern European countries on health, as well as to assess their progress over the observed period.Methods: This research report represents a descriptive data analysis of indicators extracted from the European Health for All database. The data were analyzed using a linear trend and regression analysis to estimate the timeline changes.Results: Greece and Slovenia have the largest median values of global domestic product per capita throughout the whole period, and the largest increment trend was in Lithuania. Median value in out-of-pocket payment of THE was the highest in Albania and Ukraine, while the largest decrease in trend was noticed in Albania and Bosnia and Herzegovina. Bosnia and Herzegovina and Greece had the largest median value of THE as percentage of Gross Domestic Product (GDP) in the observed period, while regression trend analysis showed that Serbia had the largest increase. Most of the countries showed a significant correlation between observed indicators.Conclusion: Trends in the economy must be constantly monitored due to the fact that the population is aging and non-communicable diseases are multiplying, which requires innovations in medical treatment and pharmaceutical development.

In the child's best interests: should life be sustained when further treatment is futile?

The aim of this article is to explore the concept of medical futility and the withdrawal of care for children in intensive care units. There have been several recent cases where medical staff have considered that there was no possibility of recovery for a child, yet their clinical judgments were challenged by the parents. The private anguish of these families became public, social media heightened emotions and this was followed by political and religious intrusion. Innovations in medical treatment and technological advances raise issues for all those involved in the care of children and young people especially when decisions need to be made about end of life care. Healthcare professionals have a moral and legal obligation to determine when treatment should cease in cases where it is determined to be futile. The aim should be to work collaboratively with parents but all decisions must be made in the best interests of the child. However, medical staff and parents may have differing opinions about care decisions. In part, this may be as a result of their unique relationships with the child and different understanding of the extent to which the child is in discomfort or can endure pain.

Does the Impact of the Tobacco Epidemic Explain Structural Changes in the Decline of Mortality?

Since 1950, most developed countries have exhibited structural changes in mortality decline. This complicates extrapolative forecasts, such as the commonly used Lee–Carter model, that require the presence of a steady long-term trend. This study tests whether the impact of the tobacco epidemic explains the structural changes in mortality decline, as it is presumed in earlier studies. For this purpose, the time index of the Lee-Carter model in males was investigated in 20 developed countries between 1950 and 2011 for possible structural changes. It was found that removing the impact of smoking from mortality trends took away more than half of the 12 detected trend breaks. For the remaining trend breaks, adjusting for smoking attenuated the degree of change in mortality decline. Taking the tobacco epidemic into account should become standard procedure in mortality forecasts to avoid a misleading extrapolation of trends. Nevertheless, more research is needed to identify additional factors, such as health-care policies and innovations in medical treatment, to explain the remaining structural changes.

The Medical Innovation Bill: Still more harm than good

The Medical Innovation Bill continues its journey through Parliament. On 23 January 2015, it was debated for the final time in the House of Lords and with one final amendment, the House moved to support the Bill, which then moved to the House of Commons on 26 January. It will be debated again on 27 February 2015. The Bill’s purpose is to encourage responsible innovation in medical treatment. Although this goal is laudable, it is argued that the Bill is unnecessary and has the potential to undermine the very cause it aims to advance. More useful for encouraging responsible innovation is the continued education of health-care professionals on how the law already supports practitioners who look to improve care through responsible innovation.

Quackery or quality: the ethicolegal basis for a legislative framework for medical innovation

Innovative therapy is a matter of recent public interest, particularly following Lord Saatchi's Medical Innovation Bill. The purpose of the Bill is to encourage responsible innovation in medical treatment. We...

SURGICAL TREATMENT OF CHRONIC ULCERATIVE COLITIS

Twenty years ago ulcerative colitis was considered a disease belonging exclusively in the field of internal medicine, and the surgeon was called on to treat only certain complications that arose. The treatment of the disease process itself by surgical procedures is, relatively speaking, still in its infancy and has not yet reached the stage of universal acceptance. If one follows the history of the subject one sees surgical procedure after surgical procedure rise with a wave of enthusiasm only to be forced into the background by some innovation in medical treatment. The large number of methods of attack in use today, together with the high mortality that still prevails, make it obvious that the ideal method of treatment has not yet been discovered. In general, the surgical procedures that have been developed aim at one of three things: (1) to provide an avenue for direct irrigation of the diseased bowel